Table 1 Patient characteristics (n = 15)

From: Transarterial fiducial marker implantation for CyberKnife radiotherapy to treat pancreatic cancer: an experience with 14 cases

Characteristics Value
Sex (male: female) 10:5
Age (years)
 Mean (range) 70.6 (41–88)
Local progressiona (T2:T3:T4:recurrence) 2:2:8:3
Tumor location in pancreas (head:body:tail) 7:6:2
Lymph node metastasisa (N0:N1 and above) 11:4
Distal metastasisa (M0:M1) 12:3
History of chemotherapy (yes/no) 11:4c
 Chemotherapy before RT 7b
  GEM + S-1 1
  S-1 only 4
  GEM only 1
  nab-PTX + GEM 1
 Chemotherapy after RT 5b
 nab-PTX + GEM + nivolumab 1
 nab-PTX + GEM 1
 GEM only 1
 S-1 only 2
RT dose (Gy)
 Median (range) 50 (40–60)
RT fraction
 Median (range) 10 (5–15)
  1. RT radiotherapy, GEM gemcitabine, nab-PTX nab-paclitaxel
  2. aUICC TNM Classification of Malignant Tumors, 8th edition
  3. bAn overlap existed before and after RT